Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hyponidd-DM
- Development stage
- Unknown
- Lead developer
- Charak
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Hyponidd-DM is an approved Ayurvedic tablet formulation developed and manufactured by Charak Pharma. It is a multi-herb formulation indicated for the management of diabetes and prediabetes. The formulation contains several key active herbal ingredients, including Emblica officinalis (Amla), Curcuma longa (Haldi), Tinospora cordifolia (Guduchi), Withania coagulans (Rishyagandha), Eugenia jambolana (Raj Jambu), Gymnema sylvestre (Gudmar), Pterocarpus marsupium (Vijaysaar), and Piper nigrum (Maricha). Hyponidd-DM supports healthy blood glucose levels, improves insulin sensitivity, promotes healthy glucose metabolism, supports pancreatic function, provides antioxidant protection, and helps delay diabetes-related complications.
- Brand names
- Hyponidd-DM
- Other names
- Hyponidd DM
Beyond the preview
Go deeper on Hyponidd-DM.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hyponidd-DM.